Mei Yueh Ho
Director/Board Member presso KINPO ELECTRONICS, INC.
Profilo
Mei Yueh Ho is on the board of Kinpo Electronics, Inc., Center Laboratories, Inc., ASE Technology Holding Co., Ltd.
and Onward Therapeutics SA.
Ms. Ho previously held the position of Chairman at Council For Economic Planning & Development and Minister at Ministry of Economic Affairs.
Ms. Ho received an undergraduate degree from National Taiwan University and a graduate degree from National Chengchi University.
Posizioni attive di Mei Yueh Ho
Società | Posizione | Inizio |
---|---|---|
KINPO ELECTRONICS, INC. | Director/Board Member | 13/06/2013 |
ASE TECHNOLOGY HOLDING CO., LTD. | Director/Board Member | 21/06/2018 |
CENTER LABORATORIES, INC. | Director/Board Member | 24/06/2020 |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Director/Board Member | - |
Precedenti posizioni note di Mei Yueh Ho
Società | Posizione | Fine |
---|---|---|
AUO CORPORATION | Director/Board Member | 17/06/2022 |
AUSNUTRIA DAIRY CORPORATION LTD | Director/Board Member | 06/12/2018 |
TAIWAN PELICAN EXPRESS CO., LTD. | Director/Board Member | 01/05/2015 |
Council For Economic Planning & Development | Chairman | 01/05/2008 |
Ministry of Economic Affairs | Corporate Officer/Principal | 01/01/2006 |
Formazione di Mei Yueh Ho
National Taiwan University | Undergraduate Degree |
National Chengchi University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 7 |
---|---|
AUSNUTRIA DAIRY CORPORATION LTD | Consumer Non-Durables |
AUO CORPORATION | Electronic Technology |
KINPO ELECTRONICS, INC. | Electronic Technology |
BANK OF KAOHSIUNG CO., LTD. | Finance |
CENTER LABORATORIES, INC. | Health Technology |
TAIWAN PELICAN EXPRESS CO., LTD. | Transportation |
ASE TECHNOLOGY HOLDING CO., LTD. | Electronic Technology |
Aziende private | 4 |
---|---|
Advanced Semiconductor Engineering, Inc.
Advanced Semiconductor Engineering, Inc. SemiconductorsElectronic Technology Advanced Semiconductor Engineering, Inc. engages in the provision of independent semiconductor manufacturing services. It operates through the following segments: Packaging, Testing, and Electronic Manufacturing Services (EMS). The Packaging segment involves in the production of bare semiconductors into finished semiconductors with electrical and thermal characteristics. The Testing segment offers front-end engineering testing, wafer probing and final testing services. The EMS segment designs, assembles, and markets electronic components and telecommunications equipment motherboards. The company was founded by Chien Shen Chang and Hung Pen Chang on March 23, 1984 and is headquartered in Kaohsiung, Taiwan. | Electronic Technology |
Council For Economic Planning & Development | Government |
Ministry of Economic Affairs | |
Onward Therapeutics SA
Onward Therapeutics SA BiotechnologyHealth Technology Onward Therapeutics SA is a Swiss development stage oncology company that focuses on identifying innovative technologies and developing breakthrough medicines for cancer treatment. The private company was founded by Alain Herrera and is based in Biopole, Switzerland, a life sciences campus in Epalinges, near Lausanne. The company acquires licenses for potential development candidates and invests in partners with transformative technology platforms. Onward recently licensed a preclinical stage bispecific antibody targeting two immune checkpoints and invested in the series A financing round in Biomunex Pharmaceuticals SAS. Onward also has an affiliate in Montpellier, France, and an office in Boston. | Health Technology |